XERIS PHARMACEUTICALS INC (31) | Indenture Agreements (2)
- Second Supplemental Indenture, by and among the Registrant, Xeris Biopharma Holdings, Inc. and U.S. Bank National Association, dated October 5, 2021 (Filed With SEC on October 5, 2021)
- Base Indenture, dated as of June 30, 2020, by and between Xeris Pharmaceuticals, Inc. and U.S. Bank National Association (Filed With SEC on July 1, 2020)
